Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
prostate cancer
MedTech
FDA clears Francis Medical's water vapor prostate tumor ablation
Francis Medical garnered a 510(k) clearance for its water vapor ablation therapy for cancers of the prostate, kidneys and bladder.
Joseph Keenan
Dec 10, 2025 9:25am
FDA approves next-gen PSA test from Cleveland Diagnostics
Dec 3, 2025 10:05am
Analyst deems Janux's stock spiral an 'overreaction'
Dec 2, 2025 11:14am
J&J pays $3B cash for Halda's cancer cell death tech
Nov 17, 2025 10:19am
GSK pens $357M pact with French biotech for prostate cancer ADC
Oct 27, 2025 4:07am
Alpenglow teams up with Virdx to boost prostate cancer diagnosis
Oct 8, 2025 9:20am
